Reinhardt Max's Form 4 filing
Pacira BioSciences, Inc. (PCRX) · filed Jun 7, 2023
- Accession no.
- 0001209191-23-035260
- Filed
- Jun 7, 2023
- Trade date
- Jun 6-7, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $82.7K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reinhardt MaxCIK 0001780058 | Officer (President, Rest of World) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2023 | Common Stock | SSaleDisposed | −1,054 | $38.99 | −$41,095.46 | 30,324 | Direct | |
| Jun 7, 2023 | Common Stock | SSaleDisposed | −1,099 | $37.87 | −$41,619.13 | 29,225 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.